2,0
1. Feb. 2014
Ehemaliger Mitarbeiter, mehr als 5 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great technology on the mammo side but poor execution will take the other product lines down. They can't get out of their own way to save their lives.
Kontras
Total senior level shakeup, none of the old guard are in tact which is not a good thing. Carl Ichan is going to sell each part of the company bit by bit.